CAMBRIDGE, England--(BUSINESS WIRE)--Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its Amperia™ assay portfolio with the ...

Nomic Publishes Foundational Protein Quantification Technology in Nature Methods The company highlights how its technology powers large-scale proteomic perturbation studies, unveiling Perturb-PBMC, a ...

Abselion Launches His-tagged Protein Quantification Kit and Sensors for Amperia at PEGS Europe 2025 Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable ...

insights from industryDr. Ruizhi WangFounder and CEOAbselion In this interview, News Medical-Life Sciences speaks with Dr. Ruizhi Wang, Founder and CEO of Abselion, about simplifying the ...

Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its Amperia ™ assay portfolio with the launch of its Tagged Protein ...

Protein detection sensitivity has historically lagged behind nucleic acid detection by 2-3 orders of magnitude due to the lack of intrinsic signal amplification. While digital methods such as Single ...

Abselion establishes US subsidiary at The Engine in Cambridge, MA to support more direct engagement with researchers in North America ...

A proteomics data pipeline transforms raw mass spectrometry spectra into biologically interpretable protein-level ...

The last two weeks have been packed with collaborations for unveiling innovative products and kick-starting prosperous partnerships. From quantifying His-tagged proteins and characterizing mutations ...

When confirming antibody concentrations, sizing up proteins, or seeking the perfect formulation for a next-gen biologic, traditional approaches leave researchers tied to the lab bench for way too long ...